J Morales-Ramirez

Overview

Explore the profile of J Morales-Ramirez including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 2

Citations 211

Followers 0

Related Specialties

General Medicine

Infectious Diseases

Top 10 Co-Authors

M Thompson

B Rashbaum

E DeJesus

D Skiest

P Johnson

Y-P Liu

S Staszewski

F A Post

M Das

S E Collins

Published In

N Engl J Med

HIV Med

Affiliations

Soon will be listed here.

Recent Articles

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials

Hagins D, Orkin C, Daar E, Mills A, Brinson C, DeJesus E, et al.

HIV Med . 2018 Aug; 19(10):724-733. PMID: 30101539

Objectives: The single-tablet regimen rilpivirine, emtricitabine and tenofovir alafenamide (RPV/FTC/TAF) for treatment of HIV-1-infected adults was approved based on bioequivalence. We assessed the clinical efficacy, safety and tolerability of switching...

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

Staszewski S, Morales-Ramirez J, Tashima K, Rachlis A, Skiest D, Stanford J, et al.

N Engl J Med . 1999 Dec; 341(25):1865-73. PMID: 10601505

Background: Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz, one with a protease inhibitor and the other with two...